Interestingly, Wang et al. recently reported that high TIM-3 expression levels of T and NK cells as a whole and CD34+CD38- cells were significantly associated with a high 2-year cumulative incidence of relapse in t(8;21) AML patients (28). This evidence concerns the gene HAVCR2 and acute myeloid leukemia.